Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 16, 2023 - Issue
Submit an article Journal homepage
263
Views
7
CrossRef citations to date
0
Altmetric
RAPID COMMUNICATION

The Effects of Switching from Dipeptidyl Peptidase-4 Inhibitors to Glucagon-Like Peptide-1 Receptor Agonists on Bone Mineral Density in Diabetic Patients

Chun-Feng Huang1 Division of Family Medicine, En Chu Kong Hospital, New Taipei City, Taiwan, Republic of China;2 Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China;3 Department of Leisure Services Management, Chaoyang University of Technology, Taichung, Taiwan, Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-6265-5155
ORCID Icon,
Tso-Yen Mao3 Department of Leisure Services Management, Chaoyang University of Technology, Taichung, Taiwan, Republic of ChinaCorrespondence[email protected]
&
Shinn-Jang Hwang1 Division of Family Medicine, En Chu Kong Hospital, New Taipei City, Taiwan, Republic of China;2 Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of ChinaCorrespondence[email protected]
Pages 31-36 | Received 15 Sep 2022, Accepted 22 Dec 2022, Published online: 11 Jan 2023

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hao Liu, Faming Tian, Yunpeng Hu, Shaohua Ping & Liu Zhang. (2023) Liraglutide in Combination with Insulin Has a Superior Therapeutic Effect to Either Alone on Fracture Healing in Diabetic Rats. Diabetes, Metabolic Syndrome and Obesity 16, pages 1235-1245.
Read now

Articles from other publishers (6)

Antonella Al Refaie, Leonardo Baldassini, Caterina Mondillo, Elena Ceccarelli, Roberto Tarquini, Luigi Gennari, Stefano Gonnelli & Carla Caffarelli. (2024) Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study. Calcified Tissue International.
Crossref
Bhaskar Pal & Moitreyee Chattopadhyay. (2024) Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology. Journal of Diabetology 15:1, pages 24-37.
Crossref
Lili Huang, Wei Zhong, Xinghuan Liang, Huijuan Wang, Shi-en Fu & Zuojie Luo. (2024) Meta-Analysis on the Association Between DPP-4 Inhibitors and Bone Mineral Density and Osteoporosis. Journal of Clinical Densitometry 27:1, pages 101455.
Crossref
Rikke Viggers, Nicklas Højgaard‐hessellund Rasmussen & Peter Vestergaard. (2023) Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes—A Systematic Review. JBMR Plus 7:11.
Crossref
Ozlem Zeynep Akyay, Zeynep Canturk, Alev Selek, Berrin Cetinarslan, İlhan Tarkun, Yagmur Cakmak & Canan Baydemir. (2023) The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus. Medicine 102:39, pages e35394.
Crossref
Jakob Starup-Linde, Katrine Hygum & Bente Langdahl. (2023) Effect of incretins on skeletal health. Current Opinion in Endocrinology, Diabetes & Obesity 30:4, pages 206-212.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.